Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Migraine
Interventions
DRUG

topiramate

topiramate 25mg 1 tab in PM x 1 week topiramate 25mg 1 tab in AM / 1 tab in PM x 1 week topiramate 25mg 1 tab in AM / 2 tabs in PM x 1 week topiramate 25mg 2 tabs in AM / 2 tabs in PM x 5 weeks

DRUG

frovatriptan

frovatriptan 5mg tab during premonitory phase of migraine

Trial Locations (2)

32765

Physician Associates LLC, Oviedo

65807

Clinvest, Springfield

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

lead

Clinvest

INDIV